Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.

Fabrizio Di CostanzoFabiana NapolitanoFabio SalomoneAnna Rita AmatoGennaro AlbericoFortuna MigliaccioGiovanna PecoraroAnnachiara MarraFelice CrocettoAntonio RuffoSarah ScagliariniSabrina RossettiLivio PugliaMarilena Di NapoliRoberto BiancoAlberto Servetto Luigi Formisano

Published in: Cancers (2023)

Our analysis revealed a relevant underreporting of HRQoL in RCTs in advanced GU cancers. These results highlight the need to dedicate more attention to HRQoL in RCTs to fully assess the value of new anticancer treatments.

Keyphrases

phase iii
open label
clinical trial
working memory
double blind
phase ii
placebo controlled
randomized controlled trial
emergency department
study protocol